Taken together, the role of Lrp5 in Wnt signaling differs in tumor cells and osteocytes, and thus the therapeutic inhibition of Lrp5/Wnt signaling may weaken the intrinsic tumor-suppressing capability of osteocytes. The gene discussed is LRP5; the disease is neoplasm.